1. Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther 2022; 7: 391.
2. Abourehab MA, Pramanik S, Abdelgawad MA, Abualsoud BM, Kadi A, Ansari MJ, et al. Recent advances of chitosan formulations in biomedical applications. Int J Mol Sci 2022; 23: 10975.
3. Ogrodnik M. Cellular aging beyond cellular senescence: Markers of senescence prior to cell cycle arrest in vitro and in vivo. Aging Cell 2021; 20: e13338.
4. Zhang X-X, He S-H, Liang X, Li W, Li T-F, Li D-F. Aging, cell senescence, the pathogenesis and targeted therapies of osteoarthritis. Front Pharmacol 2021; 12: 728100.
5. Sorrenti V, Benedetti F, Buriani A, Fortinguerra S, Caudullo G, Davinelli S, et al. Immunomodulatory and antiaging mechanisms of resveratrol, rapamycin, and metformin: Focus on mTOR and AMPK signaling networks. Pharmaceuticals 2022; 15: 912.
6. Glossmann HH, Lutz O. Metformin and aging: A review. Gerontology 2019; 65: 581-590.
7. Mohammed I, Hollenberg MD, Ding H, Triggle CR. A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan. Front Endocrinol 2021; 12: 718942.
8. Larsen MT, Kuhlmann M, Hvam ML, Howard KA. Albumin-based drug delivery: Harnessing nature to cure disease. Mol Cell Ther 2016; 4: 1-12.
9. Idrees H, Zaidi SZJ, Sabir A, Khan RU, Zhang X, Hassan S-u. A review of biodegradable natural polymer-based nanoparticles for drug delivery applications. Nanomaterials 2020; 10: 1970.
10. Tran X, Mulac D, Langer K. How to deliver an unselective drug selectively: Novel puromycin-loaded albumin nanoparticles for active targeting and their controllable effectiveness. J Drug Deliv Sci Technol 2025; 106: 106701.
11. Mishra D, Hubenak JR, Mathur AB. Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy. J Biomed Mater Res A 2013; 101: 3646-3660.
12. Hong S, Choi DW, Kim HN, Park CG, Lee W, Park HH. Protein-based nanoparticles as drug delivery systems. Pharmaceutics 2020; 12: 604.
13. Wilson B, Paladugu L, Priyadarshini SB, Jenita JJL. Development of albumin-based nanoparticles for the delivery of abacavir. Int J Biol Macromol 2015; 81: 763-767.
14. Carvalho JR, Machado MV. New insights about albumin and liver disease. Ann Hepatol 2018; 17: 547-560.
15. Karimi M, Avci P, Mobasseri R, Hamblin MR, Naderi-Manesh H. The novel albumin–chitosan core–shell nanoparticles for gene delivery: Preparation, optimization and cell uptake investigation. J Nanopart Res 2013; 15: 1-14.
16. Frank LA, Onzi GR, Morawski AS, Pohlmann AR, Guterres SS, Contri RV. Chitosan as a coating material for nanoparticles intended for biomedical applications. React Funct Polym 2020; 147: 104459.
17. Caprifico AE, Foot PJS, Polycarpou E, Calabrese G. Overcoming the protein corona in chitosan-based nanoparticles. Drug Discov Today 2021; 26: 1825-1840.
18. Lee C, Choi JS, Kim I, Oh KT, Lee ES, Park ES, et al. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes. Int J Nanomedicine 2013; 8: 2975-2983.
19. Li J-m, Chen W, Wang H, Jin C, Yu X-j, Lu W-y, et al. Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro. Acta Pharmacol Sin 2009; 30: 1337-1343.
20. Piazzini V, Landucci E, D’Ambrosio M, Fasiolo LT, Cinci L, Colombo G, et al. Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery. Int J Biol Macromol 2019; 129: 267-280.
21. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4: 1798-1806.
22. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990; 9: 515-540.
23.Senthilkumar M, Amaresan N, Sankaranarayanan A. Estimation of malondialdehyde (MDA) by Thiobarbituric Acid (TBA) Assay. In: Senthilkumar M, Amaresan N, Sankaranarayanan A, editors. Plant-Microbe Interactions: Laboratory Techniques. New York, NY: Springer US; 2021. p. 103-105.
24. Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 2006; 1: 3159-3165.
25. Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: From molecular mechanisms to interventions and treatments. Signal Transduct Target Ther 2022; 7: 391.
26. Cai Y, Song W, Li J, Jing Y, Liang C, Zhang L, et al. The landscape of aging. Sci China Life Sci 2022; 65: 2354-2454.
27. Balthasar S, Michaelis K, Dinauer N, von Briesen H, Kreuter J, Langer K. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomaterials 2005; 26: 2723-2732.
28. Larsen MT, Kuhlmann M, Hvam ML, Howard KA. Albumin-based drug delivery: Harnessing nature to cure disease. Mol Cell Ther 2016; 4: 3.
29. Idrees H, Zaidi SZJ, Sabir A, Khan RU, Zhang X, Hassan SU. A review of biodegradable natural polymer-based nanoparticles for drug delivery applications. Nanomaterials (Basel) 2020; 10: 1970.
30. Hong S, Choi DW, Kim HN, Park CG, Lee W, Park HH. Protein-based nanoparticles as drug delivery systems. Pharmaceutics 2020; 12: 604.
31. He M, Fang M, Fan L, Maimaitijiang A. Preparation and characterization of BSA-loaded liraglutide and platelet fragment nanoparticle delivery system for the treatment of diabetic atherosclerosis. J Nanobiotechnology 2024; 22: 506.
32. Kong SZ, Li JC, Li SD, Liao MN, Li CP, Zheng PJ, et al. Anti-aging effect of chitosan oligosaccharide on d-galactose-induced subacute aging in mice. Mar Drugs 2018; 16: 181.
33. Salim EI, Abd El Khalik EAM, Shalaby TI, Ali EMM. Synthesis, characterisation and enhanced apoptotic effect of gemcitabine-loaded albumin nanoparticles coating with chitosan. Arch Physiol Biochem 2022; 128: 970-978.
34. Kong SZ, Li DD, Luo H, Li WJ, Huang YM, Li JC, et al. Anti-photoaging effects of chitosan oligosaccharide in ultraviolet-irradiated hairless mouse skin. Exp Gerontol 2018; 103: 27-34.
35. Malaiya A, Kenwat R, Mamgain A, Nayak P, Parker A, Paliwal SR, et al. Intranasal resveratrol delivery to the brain with chitosan-decorated bovine serum albumin nanoparticles: Advancing Alzheimer’s management in old female rats through QbD-based optimization, in vitro evaluation, and in vivo exploration. Int J Biol Macromol 2025; 311: 143300.
36. Taherian A, Esfandiari N, Rouhani S. Breast cancer drug delivery by novel drug-loaded chitosan-coated magnetic nanoparticles. Cancer Nanotechnology 2021; 12: 15.
37. Esim O, Oztuna A, Sarper M, Hascicek C. Chitosan-coated bovine serum albumin nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. J Drug Deliv Sci Technol 2022; 77: 103906
38. Piazzini V, Landucci E, D’Ambrosio M, Tiozzo Fasiolo L, Cinci L, Colombo G, et al. Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery. Int J Biol Macromol 2019; 129: 267-280.
39. Karimi M, Avci P, Mobasseri R, Hamblin MR, Naderi-Manesh H. The novel albumin–chitosan core–shell nanoparticles for gene delivery: Preparation, optimization and cell uptake investigation. J Nanopart Res 2013; 15: 1651.
40. Radwan SE-S, El-Moslemany RM, Mehanna RA, Thabet EH, Abdelfattah E-ZA, El-Kamel A. Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: In vitro and in vivo assessment. Drug Deliv 2022; 29: 1150-1163.
41. Bessone F, Dianzani C, Argenziano M, Cangemi L, Spagnolo R, Maione F, et al. Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance. Cancer Drug Resistance 2021; 4: 192.
42. Li Y, Song H, Xiong S, Tian T, Liu T, Sun Y. Chitosan-stablized bovine serum albumin nanoparticles having ability to control the release of NELL-1 protein. Int J Biol Macromol 2018; 109: 672-680.
43. Jose P, Sundar K, Anjali C, Ravindran A. Metformin-loaded BSA nanoparticles in cancer therapy: A new perspective for an old antidiabetic drug. Cell Biochem biophys 2015; 71:627-636.
44. Hasan M, Belhaj N, Benachour H, Barberi-Heyob M, Kahn CJ, Jabbari E, et al. Liposome encapsulation of curcumin: Physico-chemical characterizations and effects on MCF7 cancer cell proliferation. Int J Pharm 2014; 461: 519-528.
45. Shin GH, Chung SK, Kim JT, Joung HJ, Park HJ. Preparation of chitosan-coated nanoliposomes for improving the mucoadhesive property of curcumin using the ethanol injection method. J Agric Food Chem 2013; 61: 11119-11126.
46. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010; 75: 1-18.
47. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004; 100: 5-28.
48. Lertsutthiwong P, Noomun K, Khunthon S, Limpanart S. Influence of chitosan characteristics on the properties of biopolymeric chitosan–montmorillonite. Progress Nat Sci Mater Int 2012; 22: 502-508.
49. Prego C, García M, Torres D, Alonso MJ. Transmucosal macromolecular drug delivery. J Control Release 2005; 101: 151-162.
50. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92: 9363-9367.
51. Aibani N, Rai R, Patel P, Cuddihy G, Wasan EK. Chitosan nanoparticles at the biological interface: Implications for drug delivery. Pharmaceutics 2021; 13: 1686.
52. Fukuzawa K, Saitoh Y, Akai K, Kogure K, Ueno S, Tokumura A, et al. Antioxidant effect of bovine serum albumin on membrane lipid peroxidation induced by iron chelate and superoxide. Biochim Biophys Acta 2005; 1668: 145-155.
53. Chang HT, Cheng H, Han RM, Zhang JP, Skibsted LH. Binding to bovine serum albumin protects β-carotene against oxidative degradation. J Agric Food Chem 2016; 64: 5951-5957.
54. Ye J, Bounds A, Crumpton M, Long M, McDonough H, Srikhirisawan I, et al. Potential mechanisms of lactate dehydrogenase and bovine serum albumin proteins as antioxidants: A mixed experimental-computational study. Biochem Res Int 2025; 2025: 9638644.
55. Ngo DH, Kim SK. Antioxidant effects of chitin, chitosan, and their derivatives. Adv Food Nutr Res 2014; 73: 15-31.
56. Shang S, Li X, Wang H, Zhou Y, Pang K, Li P, et al. Targeted therapy of kidney disease with nanoparticle drug delivery materials. Bioact Mater 2024; 37: 206-221.
57. Chen S, Gan D, Lin S, Zhong Y, Chen M, Zou X, et al. Metformin in aging and aging-related diseases: Clinical applications and relevant mechanisms. Theranostics 2022; 12: 2722-2740.